Skip to main content

Table 2 Demographic and clinical data of the patients at admission to nursing homes (NH)

From: Resource Use and Disease Course in dementia - Nursing Home (REDIC-NH), a longitudinal cohort study; design and patient characteristics at admission to Norwegian nursing homes

 

All patients

Patients with dementia

Patients without dementia

p-value*

 

n= 696

n= 583

n= 113

 

Age mean (SD)

84.5 (7.5)

84.1 (7.5)

86.5 (7.0)

0.002a)

Female gender

445 (63.9)

375 (64.3)

70 (61.9)

0.630b)

Unmarried/divorced/widowed vs. married/partner n/N

478/687 (69.6)

390/576 (67.6)

88/111 (79.3)

0.015b)

 

n=516

n=428

n=88

 

Education in years – mean (SD)

8.34 (2.8)

8.30 (2.9)

8.50 (2.4)

0.549a)

Residence before admission

n=520

n=428

n=92

 

 Private home

230 (44.2)

194 (45.3)

36 (39.1)

0.278b)

 Sheltered flat

71 (13.7)

59 (13.8)

12 (13.0)

0.851b)

 Care Home (CH)

5 (1.0)

5 (1.2)

-

0.592c)

 CH with Nursing

134 (25.8)

110 (25.7)

24 (26.1)

0.939b)

 Hospital

78 (15.0)

58 (13.6)

20 (21.7)

0.046b)

 Other

2 (0.4)

2 (0.5)

-

1.000c)

Type of unit

n= 696

n= 583

n= 113

 

 Regular unit (RU)

385 (55.3)

303 (52.0)

82 (72.6)

<0.001b)

 Respite and rehabilitation unit (RRU)

85 (12.2)

64 (11.0)

21 (18.6)

0.024b)

 Special care unit (SCU)

226 (32.5)

216 (37.0)

10 (8.8)

<0.001b)

GMHR

n=666

n=557

n=109

 

 GMHR dichotomized; poor/fair

349 (52.4)

280 (50.3)

69 (63.3)

0.013b)

MOBID-2

    

 Total score

n=667

n=557

n=110

 

  mean (SD)

2.1 (2.2)

1.96 (2.1)

2.84 (2.4)

<0.001a)

 Overall pain at a 10-point scale

n=597

n=490

n=107

 

  mean (SD)

2.4 (2.5)

2.17 (2.4)

3.42 (2.8)

<0.001a)

UPDRS-6

n=528

n= 446

n=82

 

 mean (SD)

3.6 (3.7)

3.6 (3.7)

3.6 (3.4)

0.870a)

Vision

n=681

n=569

n=112

 

 Normal

161 (23.6)

138 (24.3)

23 (20.5)

0.036b)

 Mildly impaired

431 (63.3)

365 (64.1)

66 (58.9)

 Very impaired

89 (13.1)

66 (11.6)

23 (20.5)

Hearing

n=682

n=571

n=111

 

 Normal

299 (43.8)

259 (45.4)

40 (36.0)

0.193b)

 Mildly impaired

290 (42.5)

236 (41.3)

54 (48.6)

 Very impaired

93 (13.6)

76 (13.3)

17 (15.3)

Use of psychotropic medication**

n= 696

n= 583

n= 113

 

 Antipsychotics

84 (12.1)

72 (12.4)

12 (10.6)

0.605b)

 Antidepressants

199 (28.6)

167 (28.6)

32 (28.3)

0.944b)

 Anxiolytics

108 (15.5)

89 (15.3)

19 (16.8)

0.677b)

 Sedatives

167 (23.9)

128 (21.9)

39 (34.5)

0.004b)

 Anti-dementia drugs

169 (24.3)

163 (28.0)

6 (5.3)

<0.001b)

CSDD

n=657

n=548

n=109

 

 mean (SD)

6.4 (5.2)

6.6 (5.3)

5.7 (4.7)

0.094a)

PSMS

n=694

n=582

n=112

 

 mean (SD)

15.3 (4.5)

15.3 (4.5)

15.4 (4.7)

0.797a)

QoL-AD***

    

 Patient rated

n=276

n=227

n=49

 

  mean (SD)

33.1 (5.5)

32.7 (5.4)

34.7 (5.6)

0.025a)

 Staff rated

n=346

n=300

n=46

 

  mean (SD)

31.8 (5.8)

31.7 (5.7)

32.6 (6.8)

0.327a)

QUALID

n=691

n=579

n=112

 

 mean (SD)

20.0 (7.2)

20.0 (7.2)

19.4 (7.1)

0.402a)

EQ-5D

    

 Patient rated

n=219

n=172

n=47

 

  mean (SD)

3.3 (2.2)

2.9 (2.1)

4.7 (2.3)

<0.001a)

 Staff rated

n=455

n=392

n=63

 

  mean (SD)

5.3 (1.7)

5.3 (1.7)

5.5 (1.9)

0.393a)

Overall QoL VAS-scale

n=520

n=421

n=99

 

 mean (SD)

60.4 (23.5)

62.1 (23.1)

53.1 (23.7)

0.001a)

Patient rated

n=197

n=153

n=44

 

 mean (SD)

61.6 (23.5)

63.7 (23.2)

54.2 (23.4)

0.018a)

Staff rated

n=314

n=260

n=54

 

 mean (SD)

59.2 (23.2)

60.6 (22.9)

52.7 (24.0)

0.023a)

  1. All figures in (%) if not otherwise stated
  2. SD standard deviation
  3. GMHR General Medical Health Rating Scale
  4. MOBID-2 Mobilization-Observation-Behaviour-Intensity-Dementia Pain Scale
  5. UPDRS-6 Unified Parkinson’s Disease Rating Scale, six-item version
  6. CSDD Cornell scale for depression in dementia
  7. PSMS Physical Self-Maintenance Scale
  8. QoL-AD Quality of Life Alzheimer Disease
  9. QUALID Quality of Life in Late Stage Dementia
  10. EQ-5D a standardised instrument for use as a measure of health outcome
  11. QoL Quality of Life
  12. VAS Visual Analogue Scale
  13. *p-value for difference in patients with and without dementia
  14. **Psychotropic medications were grouped as: antipsychotics (N05A except lithium), antidepressants (N06A), anxiolytics (N05B), hypnotic/sedatives (N05C), and anti-dementia medication (N06D)
  15. ***In this sample, 132 patients had their QoL-AD score assessed by both themselves and staff:
  16.  Patient scored: mean 31.5 (4.9)
  17.  Staff scored: mean 34.0 (5.6)
  18.   p-value 0.000a)
  19. a) Independent Student’s t-test
  20. b) Pearson Chi-square Test
  21. c) Fisher’s Exact Test
  22. d) Mann-Whitney U Test